These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16425372)

  • 1. Relation of overexpression of S phase kinase-associated protein 2 with reduced expression of p27 and PTEN in human gastric carcinoma.
    Ma XM; Liu Y; Guo JW; Liu JH; Zuo LF
    World J Gastroenterol; 2005 Nov; 11(42):6716-21. PubMed ID: 16425372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of Skp2 expression in gastric carcinoma to expression of P27 and PTEN].
    Ma XM; Liu JH; Guo JW; Liu Y; Zuo LF
    Ai Zheng; 2006 Jan; 25(1):56-61. PubMed ID: 16405750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The expression and meanning of Skp2, p27, PTEN proteins in non-Hodgkin B-cell lymphoma of ocular adnexa].
    Zhang JJ; Zhao GQ; Lin H; Yang X; Lin J
    Zhonghua Yan Ke Za Zhi; 2012 Dec; 48(12):1107-12. PubMed ID: 23336417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
    Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M
    Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.
    Yang G; Ayala G; De Marzo A; Tian W; Frolov A; Wheeler TM; Thompson TC; Harper JW
    Clin Cancer Res; 2002 Nov; 8(11):3419-26. PubMed ID: 12429629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rosiglitazone inhibits human HepG2 cell proliferation via PI3K/PTEN/Akt signaling pathway].
    Zhang M; Peng L; Qiao Z; He H; Zhou Y; Xu Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Feb; 30(2):147-50. PubMed ID: 24491054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting the role of Skp2 suppresses cell proliferation and tumorigenesis of human gastric cancer cells via the upregulation of p27kip1.
    Wen Y; Wang K; Yang K
    Mol Med Rep; 2016 Oct; 14(4):3917-24. PubMed ID: 27572672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
    Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
    Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of SCF(SKP2) ubiquitin E3 ligase assembly and p27(KIP1) proteolysis by the PTEN pathway and cyclin D1.
    Jonason JH; Gavrilova N; Wu M; Zhang H; Sun H
    Cell Cycle; 2007 Apr; 6(8):951-61. PubMed ID: 17438373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer].
    Zheng XY; Ding W; Xie LP; Chen ZD
    Ai Zheng; 2004 Feb; 23(2):215-8. PubMed ID: 14960249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells.
    Wei Z; Jiang X; Qiao H; Zhai B; Zhang L; Zhang Q; Wu Y; Jiang H; Sun X
    Cell Signal; 2013 Apr; 25(4):931-8. PubMed ID: 23333463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic-type specific role of cell cycle regulators in non-small cell lung carcinoma.
    Zolota VG; Tzelepi VN; Leotsinidis M; Zili PE; Panagopoulos ND; Dougenis D; Tsamandas AC; Scopa CD
    J Surg Res; 2010 Dec; 164(2):256-65. PubMed ID: 19691991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic role of Skp2 and the tumor suppressor protein p27 in colorectal cancer.
    Vasile Bochis O; Achimas-Cadariu P; Vlad C; Fetica B; Corneliu Leucuta D; Ioan Busuioc C; Irimie A
    J BUON; 2017; 22(5):1122-1130. PubMed ID: 29135092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-gamma is essential in the pathogenesis of gastric carcinoma.
    Ma XM; Yu H; Huai N
    World J Gastroenterol; 2009 Aug; 15(31):3874-83. PubMed ID: 19701967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes?
    Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL
    Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.
    Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY
    Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms.
    Chen TP; Chen CM; Chang HW; Wang JS; Chang WC; Hsu SI; Cho CL
    Gynecol Oncol; 2007 Mar; 104(3):516-23. PubMed ID: 17079005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.
    Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M
    Oncol Rep; 2006 Apr; 15(4):765-71. PubMed ID: 16525656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of p27(Kip1) -interacting cell-cycle regulators in the adult testicular germ cell tumors: potential role in tumor development and histological progression.
    Miyai K; Yamamoto S; Iwaya K; Asano T; Tamai S; Tsuda H; Matsubara O
    APMIS; 2012 Nov; 120(11):890-900. PubMed ID: 23009113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of skp2 expression in primary breast cancer.
    Sonoda H; Inoue H; Ogawa K; Utsunomiya T; Masuda TA; Mori M
    Clin Cancer Res; 2006 Feb; 12(4):1215-20. PubMed ID: 16489076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.